RSV Seasonal Vaccine Introduction and Growth Strategy
H2 2024
Q3 and Year-to-date 2024 results
Full-year and Q4 2024 results
Performance vs BIU 20211
Guidance 2025
Investor roadmap over next 18 months
Execution
Portfolio
phase III and
regulatory
decisions²
Q2 2023
Q2 and Half-year
2023 results
Full-year 2023
upgraded guidance ✓
Therapy Area
Strategy
R&D priorities
Arexvy US
KK
regulatory approval ☑
Arexvy second
season data
•
BELLUS Health, Inc.
acquisition
completed
SCYNEXIS, Inc.
exclusive license
Q3 2023
Q3 and Year-to-date
2023 results
Arexvy RSV, ≥60 YOA (JP)
Arexvy, RSV, 50-59 YoA
•
Q4 2023
Full-year and Q4 2023
results
Performance vs BIU
20211
Full-year 2024 guidance
cabotegravir (long-acting), pre-exposure (EU)
Vocabria, HIV treatment (CN)
momelotinib MOMENTUM, myelofibrosis (US)
Jemperli RUBY, 1L DMMR/MSI-H EC³ (US)
Blenrep DREAMM-7/8, 2L+ multiple myeloma
°
H1 2024
Q1 2024 results
Q2 and Half-year 2024 results
MenABCWY 1st gen (US, EU) 4
°
gepotidacin EAGLE-1, GC
•
momelotinib MOMENTUM,
myelofibrosis (EU, JP)
•
Jemperli RUBY, 1L dMMR/MSI-H
EC² (EU)
•
•
Zejula FIRST IL maintenance
ovarian cancer
•
Jemperli RUBY Part 2, 1L EC³
•
•
Capital
Allocation
and
Distribution
Investor
Engagement
completed
Capital allocation
R&D and BD
priorities
TA priorities
GSK
K
> > >
Full-year 2023
dividend
declaration
Meet the management, Oncology
Roadshows
Meet the
Meet the
Meet the management,
management,
HIV
Infectious Diseases
☑
management,
Respiratory/
Immunology
Medical congresses
Arexvy, RSV, 50-59 YOA (US, EU, JP)
gepotidacin EAGLE-2/3, uUTI (US, EU)
Nucala, nasal polyposis (JP)
Nucala, severe asthma (CN)
Nucala MATINEE, COPD
depemokimab SWIFT-1/2, severe
eosinophilic asthma
depemokimab ANCHOR-1/2, CRSWNP
Zejula ZEAL, IL maintenance NSCLC
cobolimab COSTAR, 2L NSCLC
Full-year 2024 dividend declaration
1. June 2021 Investor Update 2. Includes phase III data readouts and regulatory decisions with the applicable geography denoted in brackets 3. Endometrial cancer 4. Regulatory submission and acceptance
27
22View entire presentation